Clinical Trial Update: SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating short course radiotherapy plus CAPOX chemotherapy and QL1706 for rectal cancer with liver metastases; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer with Liver Metastases

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• OXALIPLATIN (Oxaliplatin)
• QL1706

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Locally Advanced Rectal Cancer With Liver Metastases | Phase 2 | Status: RECRUITING